Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Solid Tumor 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 5Radiotherapy 3Fluorouracil 3Carboplatin 3nimotuzumab 2Taxes 2S 1 (combination) 2Radiation 2Oxaliplatin 2Nivolumab 2Ferrosoferric Oxide 2Drug Therapy 2Cisplatin 2Cetuximab 2pembrolizumab 1entinostat 1atezolizumab 1apatinib 1Watchful Waiting 1Trastuzumab 1TH 302 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Observation 1Nimodipine 1Magnetic Resonance Spectroscopy 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Neoplasms × AMG 337 × Clear all
NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡